Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,320 papers from all fields of science
Search
Sign In
Create Free Account
HER2 Positive Breast Carcinoma
Known as:
HER2 Overexpressing Subtype of Breast Carcinoma
, HER2 Overexpressing Breast Carcinoma
, HER2 Positive Breast Cancer
Expand
A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
AC-T-T Regimen
Breast
Epithelial Cells
Epithelium
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Combination of lapatinib with isothiocyanates overcomes drug resistance and inhibits migration of HER2 positive breast cancer cells
A. Kaczyńska
,
A. Herman-Antosiewicz
Breast Cancer
2016
Corpus ID: 3189914
BackgroundLapatinib is a commonly used drug that interrupts signaling from the epidermal growth factor receptors, EGFR and HER2…
Expand
2015
2015
Obesity-associated microRNA-26b regulates the proliferation of human preadipocytes via arrest of the G1/S transition.
Guang-feng Xu
,
C. Ji
,
+6 authors
Xirong Guo
Molecular Medicine Reports
2015
Corpus ID: 23449588
MicroRNAs (miRNAs) are short, 20‑24 nucleotide non‑coding RNAs, which are involved in multiple biological processes, including…
Expand
2014
2014
p53 Modulates Hsp90 ATPase Activity and Regulates Aryl Hydrocarbon Receptor Signaling
Amit Kochhar
,
L. Kopelovich
,
+4 authors
K. Subbaramaiah
Cancer Prevention Research
2014
Corpus ID: 38884547
The aryl hydrocarbon receptor (AhR), a client protein of heat shock protein 90 (Hsp90), is a ligand-activated transcription…
Expand
2013
2013
PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer.
B. Duman
,
B. Sahin
,
A. Açıkalın
,
M. Ergin
,
S. Zorludemir
Journal of B.U.ON. : official journal of the…
2013
Corpus ID: 26001871
PURPOSE Mutations that activate the PIK3CA oncogene and inhibit the tumor suppressor gene PTEN action are commonly found in…
Expand
Review
2010
Review
2010
Zinc finger protein 521, a new player in bone formation
E. Hesse
,
R. Kiviranta
,
+5 authors
R. Baron
Annals of the New York Academy of Sciences
2010
Corpus ID: 29853724
Exploration of anabolic pathways in osteoblasts revealed that Zfp521, a 30‐zinc finger protein, is highly expressed at the…
Expand
2010
2010
The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice
J. Perucho
,
M. Casarejos
,
+8 authors
M. Mena
Experimental Neurology
2010
Corpus ID: 46361923
2010
2010
Prognostic effect of hormone receptor status in early HER2 positive breast cancer patients.
H. Gómez
,
C. Castañeda
,
+8 authors
C. Vallejos
Hematology/Oncology and Stem Cell Therapy
2010
Corpus ID: 20427136
Review
2009
Review
2009
The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology.
K. Davies
Journal of Sexual Medicine
2009
Corpus ID: 37718883
INTRODUCTION The opiorphins are a newly characterized class of peptides that act as potent endogenous neutral endopeptidase (NEP…
Expand
2004
2004
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival.
N. Robert
,
B. Leyland-Jones
,
+7 authors
D. J. Slamom
Journal of Clinical Oncology
2004
Corpus ID: 196488105
573 Purpose: This randomized multicenter phase III trial evaluated the efficacy and safety of trastuzumab with paclitaxel 175 mg…
Expand
1994
1994
Suppressors of nmtl-181, a conditional lethal allele of the Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase gene, reveal proteins involved in regulating protein N-myristoylation…
D. Johnson
,
S. Cok
,
H. Feldmann
,
J. Gordon
Proceedings of the National Academy of Sciences…
1994
Corpus ID: 38736450
Several essential Saccharomyces cerevisiae proteins require myristate to be covalently bound to their amino-terminal glycine for…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE